Deutetrabenazine (Teva Neuroscience, Inc, Parsippany, NJ) is a VMAT2 inhibitor approved by the USFDA in adults for treatment of TD and chorea associated with HD.18 This evidence concerns the gene SLC18A2 and thanatophoric dysplasia.